Search research articles
Contact Us
Filters
Showing results (151-160 of 176) with videos related to
Page
of 18
Sort By:
Cell Stem Cell
|
June 3, 2018
Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia
Michael Y Choi, George F Widhopf, Emanuela M Ghia, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 10, 2019
Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody
Suping Zhang, Han Zhang, Emanuela M Ghia, et al.
Journal of Translational Medicine
|
May 30, 2020
Neoadjuvant rituximab modulates the tumor immune environment in patients with high risk prostate cancer
Stephen T Ryan, Jing Zhang, Danielle N Burner, et al.
Cancer Research
|
April 21, 2011
Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer
Vered Padler-Karavani, Nancy Hurtado-Ziola, Minya Pu, et al.
EGEMS (Washington, DC)
|
June 9, 2018
A Framework for Leveraging "Big Data" to Advance Epidemiology and Improve Quality: Design of the VA Colonoscopy Collaborative
Samir Gupta, Lin Liu, Olga V Patterson, et al.
Cell Reports
|
September 26, 2019
Oligogenic Effects of 16p11.2 Copy-Number Variation on Craniofacial Development
Yuqi Qiu, Thomas Arbogast, Sandra Martin Lorenzo, et al.
Breast Cancer Research : BCR
|
February 26, 2024
A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic Her2-negative breast cancer
Rebecca A Shatsky, Hemali Batra-Sharma, Teresa Helsten, et al.
Oncotarget
|
October 6, 2017
A cerebrospinal fluid microRNA signature as biomarker for glioblastoma
Johnny C Akers, Wei Hua, Hongying Li, et al.
The Lancet. Oncology
|
May 14, 2021
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial
Assuntina G Sacco, Ruifeng Chen, Francis P Worden, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Howard H Feldman, Karen Messer, Jing Zhang, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 176) with videos related to
Sort By:
Page
of 18
Cell Stem Cell
|
June 3, 2018
Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia
Michael Y Choi, George F Widhopf, Emanuela M Ghia, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 10, 2019
Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody
Suping Zhang, Han Zhang, Emanuela M Ghia, et al.
Journal of Translational Medicine
|
May 30, 2020
Neoadjuvant rituximab modulates the tumor immune environment in patients with high risk prostate cancer
Stephen T Ryan, Jing Zhang, Danielle N Burner, et al.
Cancer Research
|
April 21, 2011
Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer
Vered Padler-Karavani, Nancy Hurtado-Ziola, Minya Pu, et al.
EGEMS (Washington, DC)
|
June 9, 2018
A Framework for Leveraging "Big Data" to Advance Epidemiology and Improve Quality: Design of the VA Colonoscopy Collaborative
Samir Gupta, Lin Liu, Olga V Patterson, et al.
Cell Reports
|
September 26, 2019
Oligogenic Effects of 16p11.2 Copy-Number Variation on Craniofacial Development
Yuqi Qiu, Thomas Arbogast, Sandra Martin Lorenzo, et al.
Breast Cancer Research : BCR
|
February 26, 2024
A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic Her2-negative breast cancer
Rebecca A Shatsky, Hemali Batra-Sharma, Teresa Helsten, et al.
Oncotarget
|
October 6, 2017
A cerebrospinal fluid microRNA signature as biomarker for glioblastoma
Johnny C Akers, Wei Hua, Hongying Li, et al.
The Lancet. Oncology
|
May 14, 2021
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial
Assuntina G Sacco, Ruifeng Chen, Francis P Worden, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Howard H Feldman, Karen Messer, Jing Zhang, et al.
Page
of 18